tiprankstipranks
Trending News
More News >
Cannapharmarx Inc (CPMD)
OTHER OTC:CPMD
US Market

Cannapharmarx (CPMD) Ratios

Compare
58 Followers

Cannapharmarx Ratios

CPMD's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, CPMD's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.05 0.07 <0.01 <0.01 0.03
Quick Ratio
0.02 <0.01 <0.01 <0.01 0.03
Cash Ratio
<0.01 <0.01 <0.01 <0.01 0.02
Solvency Ratio
-0.21 0.16 -0.36 -0.79 -1.26
Operating Cash Flow Ratio
-0.04 -0.13 -0.08 -0.19 -0.03
Short-Term Operating Cash Flow Coverage
-0.09 -0.32 -0.16 -0.27 -0.06
Net Current Asset Value
$ -32.66M$ -22.70M$ -22.66M$ -13.01M$ -17.08M
Leverage Ratios
Debt-to-Assets Ratio
1.15 1.10 2.68 78.89 1.14
Debt-to-Equity Ratio
-0.59 -1.06 -0.84 -0.70 -1.14
Debt-to-Capital Ratio
-1.46 16.54 -5.15 -2.31 8.34
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
-0.52 -0.97 -0.31 >-0.01 -0.99
Debt Service Coverage Ratio
-0.22 -0.17 -0.68 -0.39 -1.61
Interest Coverage Ratio
-3.64 -0.93 -2.28 -1.99 -6.32
Debt to Market Cap
5.77 13.35 4.23 9.33 0.50
Interest Debt Per Share
0.02 0.05 0.08 0.14 0.30
Net Debt to EBITDA
-4.17 -8.94 -2.96 -3.44 -0.55
Profitability Margins
Gross Profit Margin
-165.05%0.00%0.00%0.00%0.00%
EBIT Margin
-137.83%0.00%0.00%0.00%0.00%
EBITDA Margin
-188.09%0.00%0.00%0.00%0.00%
Operating Profit Margin
-232.50%0.00%0.00%0.00%0.00%
Pretax Profit Margin
-429.35%0.00%0.00%0.00%0.00%
Net Profit Margin
-429.35%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
-342.71%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%117.07%111.53%
EBT Per EBIT
184.67%-233.28%163.69%295.09%137.31%
Return on Assets (ROA)
-63.04%31.40%-157.57%-9043.90%-253.60%
Return on Equity (ROE)
34.30%-30.35%49.19%79.99%252.05%
Return on Capital Employed (ROCE)
23.52%24.63%44.35%23.16%164.59%
Return on Invested Capital (ROIC)
113.87%-202.14%267.94%89.69%-1347.00%
Return on Tangible Assets
-63.04%31.40%-157.57%-9043.90%-253.60%
Earnings Yield
-315.83%702.30%-404.23%-1069.06%-111.24%
Efficiency Ratios
Receivables Turnover
2.90 0.00 0.00 0.00 0.00
Payables Turnover
0.00 0.01 0.04 <0.01 0.04
Inventory Turnover
4.47 0.06 4.30 -8.11 -233.22
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.15 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
-0.06 0.00 0.00 0.00 0.00
Cash Conversion Cycle
207.51 -24.84K -8.48K -79.56K -10.18K
Days of Sales Outstanding
125.91 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
81.60 6.31K 84.82 -45.00 -1.57
Days of Payables Outstanding
0.00 31.15K 8.57K 79.52K 10.18K
Operating Cycle
207.51 6.31K 84.82 -45.00 -1.57
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 >-0.01 >-0.01 -0.03 -0.01
Free Cash Flow Per Share
>-0.01 >-0.01 >-0.01 -0.03 -0.01
CapEx Per Share
0.00 <0.01 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.04 1.08 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 -28.21 -12.49 -385.54 0.00
Capital Expenditure Coverage Ratio
0.00 -28.21 -12.49 -385.54 0.00
Operating Cash Flow Coverage Ratio
-0.09 -0.18 -0.10 -0.27 -0.06
Operating Cash Flow to Sales Ratio
-0.72 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-52.95%-448.42%-74.12%-250.30%-2.83%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.32 0.14 -0.25 -0.09 -0.90
Price-to-Sales (P/S) Ratio
1.36 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
-0.10 -0.04 -0.12 -0.07 -2.27
Price-to-Free Cash Flow (P/FCF) Ratio
-1.89 -0.22 -1.35 -0.40 -35.39
Price-to-Operating Cash Flow Ratio
-1.89 -0.23 -1.46 -0.40 -35.39
Price-to-Earnings Growth (PEG) Ratio
0.01 >-0.01 <0.01 <0.01 0.03
Price-to-Fair Value
-0.10 -0.04 -0.12 -0.07 -2.27
Enterprise Value Multiple
-4.89 -9.30 -3.39 -3.81 -1.70
Enterprise Value
15.70M 13.46M 16.63M 9.96M 29.61M
EV to EBITDA
-4.89 -9.30 -3.39 -3.81 -1.70
EV to Sales
9.20 0.00 0.00 0.00 0.00
EV to Free Cash Flow
-12.79 -5.72 -10.63 -4.11 -52.54
EV to Operating Cash Flow
-12.79 -5.92 -11.48 -4.12 -52.54
Tangible Book Value Per Share
-0.03 -0.04 -0.08 -0.17 -0.22
Shareholders’ Equity Per Share
-0.03 -0.04 -0.08 -0.17 -0.22
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 -0.32 -0.17 -0.12
Revenue Per Share
<0.01 0.00 0.00 0.00 0.00
Net Income Per Share
-0.01 0.01 -0.04 -0.14 -0.55
Tax Burden
1.00 1.00 1.00 1.17 1.12
Interest Burden
3.12 -2.34 1.64 1.21 1.13
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.43 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.21 -0.62 0.17 0.27 0.03
Currency in USD